Pedro P. Lopez-Casas

Pedro P. Lopez-Casas

Spanish National Cancer Research Center - Madrid / Spain
Others
AD Scientific Index ID: 4516277
Centro Nacional de Investigaciones Oncológicas de España
person_outline Pedro P. Lopez-Casas's MOST POPULAR ARTICLES
1-) Stromal disrupting effects of nab-paclitaxel in pancreatic cancerR Alvarez, M Musteanu, E Garcia-Garcia, PP Lopez-Casas, D Megias, ...British journal of cancer 109 (4), 926-933, 20132712013
2-) Integrated next-generation sequencing and avatar mouse models for personalized cancer treatmentE Garralda, K Paz, PP López-Casas, S Jones, A Katz, LM Kann, ...Clinical Cancer Research 20 (9), 2476-2484, 20141592014
3-) CDK4/6 inhibitors impair recovery from cytotoxic chemotherapy in pancreatic adenocarcinomaB Salvador-Barbero, M Álvarez-Fernández, E Zapatero-Solana, ...Cancer Cell 37 (3), 340-353. e6, 20201432020
4-) SPARC expression did not predict efficacy of nab-paclitaxel plus gemcitabine or gemcitabine alone for metastatic pancreatic cancer in an exploratory analysis of the phase III …M Hidalgo, C Plaza, M Musteanu, P Illei, CB Brachmann, C Heise, ...Clinical Cancer Research 21 (21), 4811-4818, 20151452015
5-) Glesatinib Exhibits Antitumor Activity in Lung Cancer Models and Patients Harboring MET Exon 14 Mutations and Overcomes Mutation-mediated Resistance to Type I MET Inhibitors in …LD Engstrom, R Aranda, M Lee, EA Tovar, CJ Essenburg, Z Madaj, ...Clinical Cancer Research 23 (21), 6661-6672, 20171352017